Furthermore, PHBP mRNA levels were found to be upregulated in non-small-cell lung cancer (NSCLC) [104], while a downregulation and loss of function mutation of HABP2 were seen in head and neck squamous cell carcinoma [105] and thyroid carcinoma [106], separately. The gene discussed is HABP2; the disease is head and neck squamous cell carcinoma.